Novartis Institutes for BioMedical Research (NIBR)
The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization of Novartis. With approximately 5 000 scientists and physicians around the world, our research is focused on discovering innovative new drugs that will change the practice of medicine. We have an open and entrepreneurial culture, encouraging collaboration to make effective therapies.
Drug discovery and development process
Focus on patients
We are dedicated to creating value for patients.